Drug Shortage Report for JAMP-SOTALOL
Report ID | 30040 |
Drug Identification Number | 02368625 |
Brand name | JAMP-SOTALOL |
Common or Proper name | Sotalol |
Company Name | JAMP PHARMA CORPORATION |
Market Status | DORMANT |
Active Ingredient(s) | SOTALOL HYDROCHLORIDE |
Strength(s) | 160MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C07AA |
ATC description | BETA BLOCKING AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-11-20 |
Estimated end date | |
Actual end date | 2018-07-04 |
Shortage status | Resolved |
Updated date | 2018-07-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2018-07-05 | English | Compare |
v6 | 2018-07-04 | French | Compare |
v5 | 2018-07-04 | English | Compare |
v4 | 2018-03-29 | French | Compare |
v3 | 2018-03-29 | English | Compare |
v2 | 2017-11-21 | French | Compare |
v1 | 2017-11-21 | English | Compare |
Showing 1 to 7 of 7